Form 8-K - Current report:
SEC Accession No. 0001493152-19-002224
Filing Date
2019-02-19
Accepted
2019-02-19 06:15:17
Documents
31
Period of Report
2019-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 26603
2 ex99-1.htm EX-99.1 22375
3 ex99-1_001.jpg GRAPHIC 45405
4 ex99-1_002.jpg GRAPHIC 265746
5 ex99-1_003.jpg GRAPHIC 184417
6 ex99-1_004.jpg GRAPHIC 170541
7 ex99-1_005.jpg GRAPHIC 238786
8 ex99-1_006.jpg GRAPHIC 119222
9 ex99-1_007.jpg GRAPHIC 92984
10 ex99-1_008.jpg GRAPHIC 89305
11 ex99-1_009.jpg GRAPHIC 100757
12 ex99-1_010.jpg GRAPHIC 99214
13 ex99-1_011.jpg GRAPHIC 96519
14 ex99-1_012.jpg GRAPHIC 125330
15 ex99-1_013.jpg GRAPHIC 113771
16 ex99-1_014.jpg GRAPHIC 131013
17 ex99-1_015.jpg GRAPHIC 129611
18 ex99-1_016.jpg GRAPHIC 186080
19 ex99-1_017.jpg GRAPHIC 112649
20 ex99-1_018.jpg GRAPHIC 121088
21 ex99-1_019.jpg GRAPHIC 114137
22 ex99-1_020.jpg GRAPHIC 119063
23 ex99-1_021.jpg GRAPHIC 108459
24 ex99-1_022.jpg GRAPHIC 126475
25 ex99-1_023.jpg GRAPHIC 173391
26 ex99-1_024.jpg GRAPHIC 128851
27 ex99-1_025.jpg GRAPHIC 124293
28 ex99-1_026.jpg GRAPHIC 160820
29 ex99-1_027.jpg GRAPHIC 191899
30 ex99-1_028.jpg GRAPHIC 128125
31 ex99-1_029.jpg GRAPHIC 92400
  Complete submission text file 0001493152-19-002224.txt   5410609
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 19613290
SIC: 7389 Services-Business Services, NEC